Final Program in it's entirety - MyGirlsBlood
Final Program in it's entirety - MyGirlsBlood
Final Program in it's entirety - MyGirlsBlood
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Posters, Tuesday and Wednesday<br />
Index of Poster Presenters cont’d<br />
22P39<br />
Association of Self-Reported Jo<strong>in</strong>t Pa<strong>in</strong> and Motion Limitation<br />
with Cl<strong>in</strong>ical Range of Motion Assessment <strong>in</strong> Patients with<br />
Hemophilia A<br />
Zhou Z-Y1 , Johnson K1 , Koerper M2 , Wu J1 , Curtis R3 , Riske<br />
B4 , Forsberg A5 , Ullman M6 , Lou M1 1 2 University of Southern California, CA, U.S.A., University of<br />
California, San Francisco, CA, U.S.A., 3Department of Health<br />
Services, Richmond, CA, U.S.A., 4University of Colorado<br />
Denver, CO, U.S.A., 5UMass Memorial Hospital, MA, U.S.A.,<br />
6University of Texas Health Science at Houston, TX, U.S.A.<br />
OTHER<br />
24P05<br />
Venous Thromboembolism <strong>in</strong> Males with a Severe Form of<br />
Hemophilia: The Experience of One Centre<br />
Dulíèek P1 , Malý J1 , Pecka M1 , Beránek M2 1Internal Department, Division of Hematology and<br />
2Department of Cl<strong>in</strong>ical Biochemistry, Charles University,<br />
Hradec Králové, Czech Republic<br />
24P06<br />
Immunologic Reactivity <strong>in</strong> Patients with Hemophilia<br />
Kazimova M<br />
Azerbaijan State Advanced Tra<strong>in</strong><strong>in</strong>g Institute, Baku,<br />
Azerbaijan<br />
24P07<br />
EUHASS: The First 12 Months of a European Adverse Event<br />
Report<strong>in</strong>g System for Hemophilia<br />
Markis, M<br />
Royal Hallamshire Hospital, Sheffield, United K<strong>in</strong>gdom<br />
24P08<br />
Apply<strong>in</strong>g New Technologies When Tak<strong>in</strong>g Care of Hemophilia<br />
Patients<br />
Montaño Mejía CA<br />
Bogota, Colombia<br />
24P09<br />
Thromboelastography Reveals K<strong>in</strong>etics of LPS-Induced<br />
Coagulopathy and Correlates to Fetal Outcome <strong>in</strong> a Rat<br />
Model of Pregnancy Complications<br />
Othman M, Renaud S, Quirt J, MacDonald-Goodfellow S,<br />
and Graham C<br />
Laurentian University- St Lawrence College Collaborative<br />
BScN <strong>Program</strong>, K<strong>in</strong>gston, ON, Canada<br />
78<br />
24P10<br />
Trauma-Related Bleed<strong>in</strong>g Complications <strong>in</strong> South African<br />
Hemophilia Patients (2000–2009): Cl<strong>in</strong>ical Presentation,<br />
Management, and Prognostic Factors<br />
Sissolak G 1 , Dippenaar A 1 , Cruickshank A-L 2 , Desai F 3 ,<br />
Karabus C, McDonald A 2<br />
Tygerberg Hospital Haemophilia Comprehensive Treatment<br />
Centre 1 , Groote Schuur Hospital Haemophilia Comprehensive<br />
Treatment Centre 2 , Red Cross War Memorial Children’s<br />
Hospital Haemophilia Comprehensive Treatment Centre 3 ,<br />
Cape Town, South Africa<br />
OTHER TREATMENT MODALITIES<br />
25P02<br />
MRI and US: Look<strong>in</strong>g for a Precocious Diagnosis of Jo<strong>in</strong>t<br />
Diseases<br />
Aparisi Rodriguez F, Querol Fuentes F, Beltran Mayor J,<br />
Cifrian Cavada C, Ramirez Latorre O, Gomez J<br />
Hospital La Fe, Valencia, Spa<strong>in</strong><br />
25P03<br />
Aga<strong>in</strong>st the Prejudice - Ethic Use of Factor VIII Products <strong>in</strong><br />
the Adolescent Population Dur<strong>in</strong>g Social Interventions &<br />
Hemophiliac Camps<br />
Balliel W1 , Hamulyak K2 1 2 AUGMENTO - HTC and Department of Hematology,<br />
Maastricht UMC, Maastricht, the Netherlands<br />
25P04<br />
Case Report on Intra-Articular Hyaluronic Acid <strong>in</strong> the<br />
Treatment of Chronic Hemophilic Arthropathy <strong>in</strong> a Patient<br />
with Severe Hemophilia A<br />
Chan R, Osip J, Baumann K, Red<strong>in</strong>g M<br />
University of M<strong>in</strong>nesota Medical Center, Fairview, Center for<br />
Bleed<strong>in</strong>g and Clott<strong>in</strong>g Disorders, M<strong>in</strong>neapolis, MN, U.S.A.<br />
25P05<br />
Manag<strong>in</strong>g Hemorrhagic and Thromboembolic Risk <strong>in</strong> Patients<br />
with Acquired Hemophilia<br />
Coppola A, Tufano A, Cim<strong>in</strong>o E, Guida A, Battipaglia G, Di<br />
M<strong>in</strong>no MND<br />
Regional Reference Centre for Coagulation Disorders,<br />
Federico II University, Naples, Italy<br />
25P06<br />
Procoagulant Activity of Sulfated Polysaccharides<br />
Dockal M, Knappe S, Panholzer E, Palige M, Ehrlich H,<br />
Scheifl<strong>in</strong>ger F<br />
Baxter Innovations GmbH, Orth Donau, Austria